Andalusian Stem Cell Bank (Spanish Central Node), Hospital Universitario Virgen de las Nieves, Avda Fuerzas Armadas, 2, 18014, Granada, Spain,
Cytotechnology. 2006 Sep;52(1):1-11. doi: 10.1007/s10616-006-9031-6. Epub 2006 Nov 25.
With the introduction of regenerative medicine and cell therapy programmes by means of human embryonic stem cells (hESC), several research centres have begun projects of derivation of hESC lines. In some stem cell banks, such as the Andalusian Stem Cell Bank, the law also permits the creation of these cell lines. Therefore, the recovery of cryopreserved embryos, their culture and the subsequent derivation to hESC lines requires a suitable embryology laboratory and specialized and highly qualified staff. Moreover, new techniques, from therapeutic nuclear transfer, need this type of laboratory and staff, too. Several International Associations have drawn up some guidelines for laboratories where embryos are manipulated and they reflect the physical space, the staff and the equipment needed in these kinds of laboratories. Nevertheless, we can see that these guidelines do not distinguish between IVF laboratories and other laboratories that obtain hESC lines, so it would be convenient to make a distinction. Following these guidelines, we have tried to draw up concurrent aspects applicable to areas of embryology within stem cell banks. So, the design and the specific implementation programmes for these areas and other research centres with this area but which do not use IVF techniques is vital to develop embryonic cell lines in optimum conditions for future therapeutic applications, although maybe it is rather premature to standardize this type of research.
随着再生医学和细胞疗法计划的引入,通过人类胚胎干细胞(hESC),一些研究中心已经开始了 hESC 系的衍生项目。在一些干细胞库中,如安达卢西亚干细胞库,法律也允许创建这些细胞系。因此,需要一个合适的胚胎学实验室和专业且高素质的工作人员来回收冷冻保存的胚胎、培养它们并随后衍生为 hESC 系。此外,从治疗性核转移等新技术也需要这种类型的实验室和工作人员。一些国际协会已经为胚胎操作的实验室制定了一些指南,这些指南反映了这些实验室所需的物理空间、人员和设备。然而,我们可以看到,这些指南并没有区分体外受精实验室和其他获得 hESC 系的实验室,因此区分一下会很方便。根据这些指南,我们试图制定适用于干细胞库中胚胎学领域的并行方面。因此,设计和具体实施这些领域的方案以及其他使用 IVF 技术的研究中心对于在未来治疗应用中以最佳条件开发胚胎细胞系至关重要,尽管规范这种类型的研究可能还为时过早。